Among 14 common types of protective face mask is one that may do more harm than good.

It’s no shock to find Massachusetts and Minnesota topping the states as the best in which to receive high-quality healthcare with good access and reasonable out-of-pocket prices. But look which state leads the way in getting at-risk adults to the doctor for routine visits.

The honor roll, which recognizes 20 hospitals that excel in numerous care concentrations, is only part of a “Best Hospitals” package the publication has retooled for this, the year of the pandemic. 

Maine has topped all states in two separate five-year categories of hospital safety—percentage of “A” grade hospitals (57.1%) and average annual placement in these rankings (3.63). How did your state do?

The number of COVID-19 infections is likely ten times higher than the reported numbers, which could put the number of cases in the U.S. at 23 million, according to CDC Director Robert Redfield, MD.

A new study shows that as much as 80% of COVID-19 cases in the early days of the pandemic went undetected as a result of poor testing capabilities in March.

A commonly known steroid drug has been found to greatly improve survival for COVID-19 patients. In fact, among severe patients, the steroid, Dexamethasone, reduced the number of deaths by one-third in a study conducted by the University of Oxford.

Two major journals in the healthcare space are reviewing what happened and how to move forward with data requirements after a controversial study on the impact of hydroxychloroquine led to a retraction and backlash.

Centene, one of the nation’s largest insurance and managed care companies, has teamed up with the National Minority Quality Forum (NMQF) to launch a research partnership that will dive into the impacts of COVID-19 on minorities.

Three authors of a research study on the efficacy of hydroxychloroquine in COVID-19 patients published in The Lancet have retracted their paper after it was met with backlash and scientific questions.

The Lancet has issued four corrections to a research paper that found COVID-19 patients who used the drug hydroxychloroquine have a higher risk of death.

A group consisting of 140 scientists and physicians has spoken out against a study published in The Lancet that found an association between the use of the drug hydroxychloroquine and a higher death rate among COVID-19 patients.